Indium-111 Capromab Pendetide (ProstaScint®) Demonstrates Renal Cell Carcinoma and Aortocaval Nodal Metastases from Prostate Adenocarcinoma

A 62-year-old male with a history of radical prostatectomy for a Gleason 9 (4 + 5) pT3N0Mx prostate cancer presented with rising prostate-specific antigen of 9.0 ng/dl. A contrast-enhanced computerized tomography (CT) revealed an enhancing left upper pole renal mass and aortocaval lymph nodes. Indiu...

Full description

Saved in:
Bibliographic Details
Main Authors: Tanvir Rizvi, Chunli Deng, Patrice Rehm
Format: Article
Language:English
Published: Thieme Medical and Scientific Publishers Pvt. Ltd. 2015-07-01
Series:World Journal of Nuclear Medicine
Subjects:
Online Access:http://www.thieme-connect.de/DOI/DOI?10.4103/1450-1147.163259
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849324721567432704
author Tanvir Rizvi
Chunli Deng
Patrice Rehm
author_facet Tanvir Rizvi
Chunli Deng
Patrice Rehm
author_sort Tanvir Rizvi
collection DOAJ
description A 62-year-old male with a history of radical prostatectomy for a Gleason 9 (4 + 5) pT3N0Mx prostate cancer presented with rising prostate-specific antigen of 9.0 ng/dl. A contrast-enhanced computerized tomography (CT) revealed an enhancing left upper pole renal mass and aortocaval lymph nodes. Indium (In)-111 Capromab Pendetide (ProstaScint ® ) single-photon emission computerized tomography-CT showed abnormal increased uptake in left renal mass and aortocaval lymph nodes with no uptake in the prostate bed or pelvic lymph nodes. He underwent left radical nephrectomy and dissection of aortocaval lymph nodes. Pathology showed renal clear cell carcinoma and metastatic prostate adenocarcinoma involving aortocaval lymph nodes. Our case demonstrates a rare combination of two different malignancies, prostate cancer and clear cell renal cell cancer, showing In-111 ProstaScint ® uptake. Though ProstaScint ® uptake in renal cell carcinoma and in metastatic aortocaval lymph nodes from prostate cancer may be seen in clinical practice, this combination has not been reported previously.
format Article
id doaj-art-c5ddbcc4090541eea2a86caf60beaa60
institution Kabale University
issn 1450-1147
1607-3312
language English
publishDate 2015-07-01
publisher Thieme Medical and Scientific Publishers Pvt. Ltd.
record_format Article
series World Journal of Nuclear Medicine
spelling doaj-art-c5ddbcc4090541eea2a86caf60beaa602025-08-20T03:48:36ZengThieme Medical and Scientific Publishers Pvt. Ltd.World Journal of Nuclear Medicine1450-11471607-33122015-07-01140320921110.4103/1450-1147.163259Indium-111 Capromab Pendetide (ProstaScint®) Demonstrates Renal Cell Carcinoma and Aortocaval Nodal Metastases from Prostate AdenocarcinomaTanvir Rizvi0Chunli Deng1Patrice Rehm2Department of Radiology and Medical Imaging, University of Virginia Health System, Charlottesville, VA 22908Department of Radiology, Cincinnati VA Health System, Cincinnati, OH 45220, USADepartment of Radiology and Medical Imaging, University of Virginia Health System, Charlottesville, VA 22908A 62-year-old male with a history of radical prostatectomy for a Gleason 9 (4 + 5) pT3N0Mx prostate cancer presented with rising prostate-specific antigen of 9.0 ng/dl. A contrast-enhanced computerized tomography (CT) revealed an enhancing left upper pole renal mass and aortocaval lymph nodes. Indium (In)-111 Capromab Pendetide (ProstaScint ® ) single-photon emission computerized tomography-CT showed abnormal increased uptake in left renal mass and aortocaval lymph nodes with no uptake in the prostate bed or pelvic lymph nodes. He underwent left radical nephrectomy and dissection of aortocaval lymph nodes. Pathology showed renal clear cell carcinoma and metastatic prostate adenocarcinoma involving aortocaval lymph nodes. Our case demonstrates a rare combination of two different malignancies, prostate cancer and clear cell renal cell cancer, showing In-111 ProstaScint ® uptake. Though ProstaScint ® uptake in renal cell carcinoma and in metastatic aortocaval lymph nodes from prostate cancer may be seen in clinical practice, this combination has not been reported previously.http://www.thieme-connect.de/DOI/DOI?10.4103/1450-1147.163259clear cell renal carcinomaprostascint ® scanprostate cancer
spellingShingle Tanvir Rizvi
Chunli Deng
Patrice Rehm
Indium-111 Capromab Pendetide (ProstaScint®) Demonstrates Renal Cell Carcinoma and Aortocaval Nodal Metastases from Prostate Adenocarcinoma
World Journal of Nuclear Medicine
clear cell renal carcinoma
prostascint ® scan
prostate cancer
title Indium-111 Capromab Pendetide (ProstaScint®) Demonstrates Renal Cell Carcinoma and Aortocaval Nodal Metastases from Prostate Adenocarcinoma
title_full Indium-111 Capromab Pendetide (ProstaScint®) Demonstrates Renal Cell Carcinoma and Aortocaval Nodal Metastases from Prostate Adenocarcinoma
title_fullStr Indium-111 Capromab Pendetide (ProstaScint®) Demonstrates Renal Cell Carcinoma and Aortocaval Nodal Metastases from Prostate Adenocarcinoma
title_full_unstemmed Indium-111 Capromab Pendetide (ProstaScint®) Demonstrates Renal Cell Carcinoma and Aortocaval Nodal Metastases from Prostate Adenocarcinoma
title_short Indium-111 Capromab Pendetide (ProstaScint®) Demonstrates Renal Cell Carcinoma and Aortocaval Nodal Metastases from Prostate Adenocarcinoma
title_sort indium 111 capromab pendetide prostascint r demonstrates renal cell carcinoma and aortocaval nodal metastases from prostate adenocarcinoma
topic clear cell renal carcinoma
prostascint ® scan
prostate cancer
url http://www.thieme-connect.de/DOI/DOI?10.4103/1450-1147.163259
work_keys_str_mv AT tanvirrizvi indium111capromabpendetideprostascintdemonstratesrenalcellcarcinomaandaortocavalnodalmetastasesfromprostateadenocarcinoma
AT chunlideng indium111capromabpendetideprostascintdemonstratesrenalcellcarcinomaandaortocavalnodalmetastasesfromprostateadenocarcinoma
AT patricerehm indium111capromabpendetideprostascintdemonstratesrenalcellcarcinomaandaortocavalnodalmetastasesfromprostateadenocarcinoma